Top Markets
Coin of the day
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Rankning i aktier #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Aktiekurs
$0.00023723
Senast synkroniserad: 2024-08-26
Marknadsvärde
$1.41K
Förändring (1 dag)
111.67%
Förändring (1 år)
0.00%
Land
FR
Handel Pharnext S.A. (ALPHA)

Kategori

EPS för Pharnext S.A. (ALPHA)
EPS per December 2023 TTM: $-77.35M
Enligt Pharnext S.A.s senaste finansiella rapporter och aktiekurs är bolagets nuvarande EPS (TTM) $-77.35M. Vid slutet av 2022 hade bolaget ett EPS på $-11.16K, en minskning jämfört med EPS från 2021 som var $-11.45K.
EPS-historik för Pharnext S.A. från 2013 till 2026
EPS vid slutet av varje år
År EPS Ändra
2026 (TTM) $-77.35M 35,598,509.46%
2023 $-217.28 -98.05%
2022 $-11.16K -2.49%
2021 $-11.45K 69.15%
2020 $-6.77K -21.06%
2019 $-8.57K -15.43%
2018 $-10.14K -100.00%
2017 $-6.00Qa 14.04%
2016 $-5.26Qa 44,068,612,420.18%
2015 $-11.94M -8.06%
2014 $-12.98M 1.29%
2013 $-12.82M 0.00%
EPS för liknande företag eller konkurrenter
Företag EPS EPS-differens Land
$17.32 -100.00%
US
$27.74 -100.00%
NL
- -
CH
$13.70 -100.00%
BE
- -
KR